EEG-based wearable medical device in development to predict TMS outcomes and improve depression treatment from home.
Resonait is developing a wearable medical device that translates EEG biomarkers into prognostic and therapeutic tools for depression, focusing on the default mode network (DMN). Current research projects include using EEG to predict Transcranial Magnetic Stimulation (TMS) outcomes in treatment-resistant depression in collaboration with leading clinical researchers. The device is in active research and development and is not yet a commercial product. Resonait is a product of Resonait Medical Technologies.